Companies: 48,874 Total Market Cap: 132460447025120.92

Sinopharm Group Co. Ltd.

HKG-1099
Healthcare Medical Distribution
Rank #2378
Market Cap 7.46 B
Volume 4.25 M
Price 2.39
Change (%) 1.30%
Country or region China China

Sinopharm Group Co. Ltd.'s latest marketcap:

7.46 B

As of 05/19/2025, Sinopharm Group Co. Ltd.'s market capitalization has reached $7.46 B. According to our data, Sinopharm Group Co. Ltd. is the 2378th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 7.46 B
Revenue (ttm) 79.33 B
Net Income (ttm) 971.09 M
Shares Out 3.12 B
EPS (ttm) 0.31
Forward PE 7.16
Ex-Dividend Date 06/16/2025
Earnings Date 04/25/2025
Market Cap Chart
Data Updated: 05/19/2025

Sinopharm Group Co. Ltd.'s yearly market capitalization.

Sinopharm Group Co. Ltd. has seen its market value drop from HK$58.86 B to HK$58.36 B since 2020, representing a total decrease of 0.85% and an annual compound decline rate (CAGR) of 0.19%.
Date Market Cap Change (%)
05/19/2025 HK$58.36 B -13.33%
12/31/2024 HK$66.47 B 4.16%
12/29/2023 HK$63.82 B 3.07%
12/30/2022 HK$61.91 B 16.98%
12/31/2021 HK$52.93 B -10.07%
12/31/2020 HK$58.86 B

Company Profile

About Sinopharm Group Co. Ltd.

Sinopharm Group Co. Ltd., together with its subsidiaries, operates in the wholesale and retail of pharmaceutical and medical devices, as well as healthcare products in China. Headquartered in Shanghai, the company was founded in 2003 and is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Business Segments

  • Pharmaceutical Distribution: Distributes pharmaceutical products to hospitals, clinics, and retail pharmacies. Provides logistics and value-added services for domestic and international manufacturers.
  • Medical Devices: Specializes in the distribution of medical equipment and devices.
  • Retail Pharmacy: Operates and franchises a network of retail drug stores.
  • Other Business: Engages in pharmaceutical production, chemical reagents, laboratory supplies, property management, and various consulting services.

Additional Operations

The company also offers:

  • Medical instruments and Chinese herbal medicine distribution.
  • IT services, investment, and import/export operations.
  • Health, medical, and market consulting services.
  • Medical project investment and technology training.
Frequently Asked Questions

As of 05/19/2025, Sinopharm Group Co. Ltd. (including the parent company, if applicable) has an estimated market capitalization of $7.46 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Sinopharm Group Co. Ltd. global market capitalization ranking is approximately 2378 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region China
Founded 2003
IPO Date n/a
Employees 108,217
CEO Wanyong Lian
Sector Healthcare
Industry Medical Distribution
Address Sinopharm Group Building
Shanghai, 200023
China
Website https://www.sinopharmgroup.com.cn
People Also Watch
McKesson
726.40 1.30%
Cencora
292.63 1.30%
Cardinal Health
153.86 1.30%
OTC-SIGGF
2 1.30%